GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Big Pharma Split Corp (TSX:PRM.PR.A.PFD) » Definitions » Notes Receivable

Big Pharma Split (TSX:PRM.PR.A.PFD) Notes Receivable : C$0.00 Mil (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Big Pharma Split Notes Receivable?

Big Pharma Split's Notes Receivable for the quarter that ended in Dec. 2023 was C$0.00 Mil.


Big Pharma Split Notes Receivable Historical Data

The historical data trend for Big Pharma Split's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Big Pharma Split Notes Receivable Chart

Big Pharma Split Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Notes Receivable
Get a 7-Day Free Trial - - - - -

Big Pharma Split Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Big Pharma Split Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.


Big Pharma Split Notes Receivable Related Terms

Thank you for viewing the detailed overview of Big Pharma Split's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Big Pharma Split (TSX:PRM.PR.A.PFD) Business Description

Traded in Other Exchanges
Address
610 Chartwell Road, Suite 204, Oakville, ON, CAN, L6J 4A5
Big Pharma Split Corp is a mutual fund corporation. Its investment objective is to provide shareholders with fixed cumulative preferential quarterly cash distributions, and regular monthly cash distributions. The company has a presence in the United States; Switzerland; France and United Kingdom.

Big Pharma Split (TSX:PRM.PR.A.PFD) Headlines

No Headlines